Need for Agile in Pharma sector

November 12, 2019

In order to make their process efficient, #pharmaceutical companies must bring in Agile processes. But are they really prepared?

Spotlight

Global Health Drug Discovery Institute

The Global Health Drug Discovery Institute (GHDDI) identifies and develops innovative approaches to new medicines for diseases most damaging to populations in the developing world. Diseases of particular focus are tuberculosis, malaria, diarrhea and parasitic infections etc. Being the first independent, not-for-profit research institute of its kind in China, GHDDI strives to establish a transformative drug discovery and translational platform with advanced biomedical research and development capabilities - from the bench to the bedside.

OTHER VIDEOS

Welcome to the Azelis Pharma lab in Paris, France!

video | January 30, 2023

As a leading global innovation service provider in the specialty chemicals and food ingredients industry, we are committed to creating value for principals and customers whilst providing a great work environment and career opportunities....

Watch Now

Daikyo Crystal Zenith® Insert Needle Syringe

video | January 27, 2023

The Daikyo Crystal Zenith® Insert Needle Syringe system was designed to maintain purity, integrity and efficacy of premium biopharmaceutical therapies....

Watch Now

Little Green Pharma continues to expand making significant strides

video | January 31, 2023

Leading Australian medicinal cannabis exporter, Little Green Pharma continues to expand making significant strides in lucrative global markets...

Watch Now

Teva Expands Partnership to Bring Critical Medicines to Children Living with Cancer

video | January 26, 2023

Teva believes medicine should always be accessible, and we work to help make this a reality. We're working with Global HOPE (Hematology Oncology Pediatric Excellence), a non-profit...

Watch Now

Spotlight

Global Health Drug Discovery Institute

The Global Health Drug Discovery Institute (GHDDI) identifies and develops innovative approaches to new medicines for diseases most damaging to populations in the developing world. Diseases of particular focus are tuberculosis, malaria, diarrhea and parasitic infections etc. Being the first independent, not-for-profit research institute of its kind in China, GHDDI strives to establish a transformative drug discovery and translational platform with advanced biomedical research and development capabilities - from the bench to the bedside.

Events